Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor

Leuk Lymphoma. 2020 Dec;61(13):3243-3246. doi: 10.1080/10428194.2020.1797008. Epub 2020 Jul 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clonal Evolution* / genetics
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Protein Kinase Inhibitors / therapeutic use
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • Protein Kinase Inhibitors
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • Fusion Proteins, bcr-abl